CD274 and B-cell chronic lymphocytic leukemia: These methods were dependent on a sequence of basic science discoveries [16], Dong H et al. found out that antibodies blocking the PD-L1/PD-1 interaction lead to tumor regression in mice [17], transduced T cells of chronic lymphocytic leukemia patients can effectively lyse autologous tumor cells [18].